BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Plutzky J, Viberti G, Haffner S. Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets. Journal of Diabetes and its Complications 2002;16:401-15. [DOI: 10.1016/s1056-8727(02)00202-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Chu ZG, Yang ZG, Dong ZH, Zhu ZY, Peng LQ, Shao H, He C, Deng W, Tang SS, Chen J. Characteristics of coronary artery disease in symptomatic type 2 diabetic patients: evaluation with CT angiography. Cardiovasc Diabetol 2010;9:74. [PMID: 21067585 DOI: 10.1186/1475-2840-9-74] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
2 Bruemmer D, Collins AR, Noh G, Wang W, Territo M, Arias-Magallona S, Fishbein MC, Blaschke F, Kintscher U, Graf K, Law RE, Hsueh WA. Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. J Clin Invest 2003;112:1318-31. [PMID: 14597759 DOI: 10.1172/JCI18141] [Cited by in Crossref: 8] [Cited by in F6Publishing: 107] [Article Influence: 0.4] [Reference Citation Analysis]
3 Bădulescu O, Bădescu C, Ciocoiu M, Bădescu M. Interleukin-1-beta and dyslipidemic syndrome as major risk factors for thrombotic complications in type 2 diabetes mellitus. Mediators Inflamm 2013;2013:169420. [PMID: 23401641 DOI: 10.1155/2013/169420] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
4 Hua Y, Kandadi MR, Zhu M, Ren J, Sreejayan N. Tauroursodeoxycholic acid attenuates lipid accumulation in endoplasmic reticulum-stressed macrophages. J Cardiovasc Pharmacol 2010;55:49-55. [PMID: 19834331 DOI: 10.1097/FJC.0b013e3181c37d86] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
5 Cameron-Vendrig A, Mundil D, Husain M. Antiatherothrombotic effects of dipeptidyl peptidase inhibitors. Curr Atheroscler Rep 2014;16:408. [PMID: 24623180 DOI: 10.1007/s11883-014-0408-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Tabas I, Tall A, Accili D. The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression. Circ Res 2010;106:58-67. [PMID: 20056946 DOI: 10.1161/CIRCRESAHA.109.208488] [Cited by in Crossref: 84] [Cited by in F6Publishing: 43] [Article Influence: 7.6] [Reference Citation Analysis]
7 Jiang C, Zhang H, Zhang W, Kong W, Zhu Y, Zhang H, Xu Q, Li Y, Wang X. Homocysteine promotes vascular smooth muscle cell migration by induction of the adipokine resistin. Am J Physiol Cell Physiol 2009;297:C1466-76. [PMID: 19828833 DOI: 10.1152/ajpcell.00304.2009] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
8 Li Z, Li F, Yan L, Li F, Li Y, Cheng H, Fu Z. Study on the action of resistin-induced human umbilical vein endothelial cell dysfunction. Front Med China 2007;1:196-9. [PMID: 24557676 DOI: 10.1007/s11684-007-0037-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Tong X, Lv P, Mathew AV, Liu D, Niu C, Wang Y, Ji L, Li J, Fu Z, Pan B. The compensatory enrichment of sphingosine -1- phosphate harbored on glycated high-density lipoprotein restores endothelial protective function in type 2 diabetes mellitus. Cardiovasc Diabetol. 2014;13:82. [PMID: 24751283 DOI: 10.1186/1475-2840-13-82] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
10 Sinha SS, Jain AK, Tyagi S, Gupta SK, Mahajan AS. Effect of 6 Months of Meditation on Blood Sugar, Glycosylated Hemoglobin, and Insulin Levels in Patients of Coronary Artery Disease. Int J Yoga 2018;11:122-8. [PMID: 29755221 DOI: 10.4103/ijoy.IJOY_30_17] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
11 Park YM, R Kashyap S, A Major J, Silverstein RL. Insulin promotes macrophage foam cell formation: potential implications in diabetes-related atherosclerosis. Lab Invest 2012;92:1171-80. [PMID: 22525426 DOI: 10.1038/labinvest.2012.74] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
12 Geloen A, Helin L, Geeraert B, Malaud E, Holvoet P, Marguerie G. CD36 inhibitors reduce postprandial hypertriglyceridemia and protect against diabetic dyslipidemia and atherosclerosis. PLoS One 2012;7:e37633. [PMID: 22662181 DOI: 10.1371/journal.pone.0037633] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
13 Tong X, Peng H, Liu D, Ji L, Niu C, Ren J, Pan B, Hu J, Zheng L, Huang Y. High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate. Cardiovasc Diabetol 2013;12:27. [PMID: 23360427 DOI: 10.1186/1475-2840-12-27] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
14 Park Y, Wu J, Zhang H, Wang Y, Zhang C. Vascular dysfunction in Type 2 diabetes: emerging targets for therapy. Expert Rev Cardiovasc Ther 2009;7:209-13. [PMID: 19296753 DOI: 10.1586/14779072.7.3.209] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]